key: cord-0702028-brxw7eat
authors: Bidar, Frank; Hamada, Sarah; Gossez, Morgane; Coudereau, Remy; Lopez, Jonathan; Cazalis, Marie-Angelique; Tardiveau, Claire; Brengel-Pesce, Karen; Mommert, Marine; Buisson, Marielle; Conti, Filippo; Rimmelé, Thomas; Lukaszewicz, Anne-Claire; Argaud, Laurent; Cour, Martin; Monneret, Guillaume; Venet, Fabienne
title: Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
date: 2022-04-01
journal: Ann Intensive Care
DOI: 10.1186/s13613-022-01007-7
sha: d5778f2e977391641b6cfb787d225d14054d1035
doc_id: 702028
cord_uid: brxw7eat

nan

In the original publication of the article [1] , the legends of x-and y-axis of panel a in Fig. 1 was inadvertently omitted. Figure 1 should have appeared as shown in this correction (Fig. 1) .

The original article has been corrected.

The original article can be found online at https:// doi. org/ 10. 1186/ s13613-022-00982-1. or down-regulated (right diagram, n = 48) genes between patients and HV are showed. c Ingenuity Pathway Analysis was applied on the list of differentially expressed genes at D0 and D20. Heatmaps of Log 10 P-value (from white indicating the absence of significance to dark red indicating a strong significance) and Z-score (from orange indicating a down-regulation to purple indicating an up-regulation) for pathways related to T cell activation at D0 and D20 are presented

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients, for the RICO study group

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations